Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07820930) titled 'A Global Randomized Trial Evaluating the FARAFLEX™ Mapping and Pulsed Field Ablation System With Electrographic Flow Mapping in Patients Undergoing Repeat Ablation for Atrial Fibrillation' on Sept. 10.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Boston Scientific Corporation
Condition:
Atrial Fibrillation (AF)
Persistent Atrial Fibrillation (PersAF)
Paroxysmal Atrial Fibrillation (PAF)
Intervention:
Device: FARAFLEX Mapping and Pulsed Field Ablation System
Recruitment St...